NCT07040215 Effects on Subacute Stroke With Robotic Assistive Gait Training
| NCT ID | NCT07040215 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Changhua Christian Hospital |
| Condition | Stroke |
| Study Type | INTERVENTIONAL |
| Enrollment | 40 participants |
| Start Date | 2025-07-01 |
| Primary Completion | 2026-04-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 40 participants in total. It began in 2025-07-01 with a primary completion date of 2026-04-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this randomized controlled trial is to learn about the effects of Robotic Assisted Gait Training (RAGT) combined with traditional physical therapy in subacute stroke patients. The main question it aims to answer is: \- Does RAGT combined with traditional physical therapy improve gait and functional performance in subacute stroke patients compared to traditional physical therapy alone? Participants who are subacute stroke patients will be randomly assigned to receive either both RAGT and traditional physical therapy or only traditional physical therapy. Their gait and functional performance will be assessed during the study period.
Eligibility Criteria
Inclusion Criteria: * Diagnosed with stroke (ischemic or hemorrhagic) confirmed by medical imaging. * Subacute phase of stroke (onset within 1 to 3 months). * Moderate to good standing balance ability. * Sufficient cognitive ability to understand the study and follow instructions. * Able to participate in rehabilitation training during the study period. Exclusion Criteria: * Body weight over 90 kg. * Presence of other neurological disorders. * Severe cardiovascular disease or other health conditions affecting mobility. * Significant lower limb pain, joint contracture, or spasticity (Modified Ashworth Scale score \> 3) that impairs walking. * Diagnosed with cardiopulmonary disease that contraindicates exercise training. * Cognitive impairment that prevents understanding of training instructions or completion of questionnaires. * Inability to complete the rehabilitation training protocol.
Contact & Investigator
Su-Fen Liao
PRINCIPAL INVESTIGATOR
Changhua Christian Hospital
Frequently Asked Questions
Who can join the NCT07040215 clinical trial?
This trial is open to participants of all sexes, aged 45 Years or older, up to 70 Years, studying Stroke. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07040215 currently recruiting?
Yes, NCT07040215 is actively recruiting participants. Contact the research team at d9010@cch.org.tw for enrollment information.
Where is the NCT07040215 trial being conducted?
This trial is being conducted at Changhua, Taiwan.
Who is sponsoring the NCT07040215 clinical trial?
NCT07040215 is sponsored by Changhua Christian Hospital. The principal investigator is Su-Fen Liao at Changhua Christian Hospital. The trial plans to enroll 40 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.